ES2328185T3 - Derivados de aril-4-etinil-isoxazol. - Google Patents
Derivados de aril-4-etinil-isoxazol. Download PDFInfo
- Publication number
- ES2328185T3 ES2328185T3 ES07729296T ES07729296T ES2328185T3 ES 2328185 T3 ES2328185 T3 ES 2328185T3 ES 07729296 T ES07729296 T ES 07729296T ES 07729296 T ES07729296 T ES 07729296T ES 2328185 T3 ES2328185 T3 ES 2328185T3
- Authority
- ES
- Spain
- Prior art keywords
- methyl
- phenyl
- iletinyl
- isoxazol
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06114745 | 2006-05-31 | ||
EP06114745 | 2006-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2328185T3 true ES2328185T3 (es) | 2009-11-10 |
Family
ID=38420559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES07729296T Active ES2328185T3 (es) | 2006-05-31 | 2007-05-21 | Derivados de aril-4-etinil-isoxazol. |
Country Status (14)
Country | Link |
---|---|
US (1) | US7544704B2 (zh) |
EP (1) | EP2029559B1 (zh) |
JP (1) | JP5087616B2 (zh) |
KR (1) | KR101119365B1 (zh) |
CN (1) | CN101454297B (zh) |
AT (1) | ATE438632T1 (zh) |
AU (1) | AU2007267183B2 (zh) |
BR (1) | BRPI0711850A2 (zh) |
CA (1) | CA2651857A1 (zh) |
DE (1) | DE602007001893D1 (zh) |
ES (1) | ES2328185T3 (zh) |
IL (1) | IL194947A0 (zh) |
MX (1) | MX2008014796A (zh) |
WO (1) | WO2007137954A1 (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2913886B1 (fr) | 2007-03-22 | 2012-03-02 | Guerbet Sa | Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer |
TW201033201A (en) * | 2009-02-19 | 2010-09-16 | Hoffmann La Roche | Isoxazole-isoxazole and isoxazole-isothiazole derivatives |
US8389550B2 (en) * | 2009-02-25 | 2013-03-05 | Hoffmann-La Roche Inc. | Isoxazoles / O-pyridines with ethyl and ethenyl linker |
US20100280019A1 (en) * | 2009-04-30 | 2010-11-04 | Roland Jakob-Roetne | Isoxazoles |
MX2011011273A (es) * | 2009-05-05 | 2011-11-04 | Hoffmann La Roche | Derivados de isoxazol-pirazol. |
JP5478716B2 (ja) * | 2009-05-05 | 2014-04-23 | エフ.ホフマン−ラ ロシュ アーゲー | 認識障害の処置において使用するためのgabaa受容体逆アゴニストとしてのイソオキサゾール−チアゾール誘導体 |
WO2010127976A1 (en) * | 2009-05-05 | 2010-11-11 | F. Hoffmann-La Roche Ag | Isoxazole-pyridine derivatives |
KR101354416B1 (ko) * | 2009-05-07 | 2014-02-19 | 에프. 호프만-라 로슈 아게 | 감마-아미노부티르산 조절제로서 이속사졸-피리딘 유도체 |
DK2702051T3 (en) | 2011-04-26 | 2015-03-16 | Hoffmann La Roche | Ethynyl derivatives AS POSITIVE allosteric modulators mGluR5 |
US8785435B2 (en) | 2011-10-20 | 2014-07-22 | Hoffmann-La Roche Inc. | Solid forms |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
WO2014001279A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
WO2014001280A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
WO2014001278A1 (en) | 2012-06-26 | 2014-01-03 | Aniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
CA2876780A1 (en) | 2012-06-26 | 2014-01-03 | Saniona Aps | A phenyl triazole derivative and its use for modulating the gabaa receptor complex |
US9206160B2 (en) | 2012-06-26 | 2015-12-08 | Saniona Aps | Phenyl triazole derivative and its use for modulating the GABAA receptor complex |
CN106146391A (zh) * | 2015-04-15 | 2016-11-23 | 中国科学院上海药物研究所 | 5-芳香炔基取代的苯甲酰胺类化合物及其制备方法、药物组合物和用途 |
BR102019014802A2 (pt) | 2018-07-20 | 2020-02-04 | Boehringer Ingelheim Int | difluorometil-fenil triazóis |
CN109793733B (zh) * | 2019-03-28 | 2021-11-12 | 四川大学 | 3-氨基-5-炔基吡唑类化合物作为fgfr抑制剂 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3525205A1 (de) | 1984-09-11 | 1986-03-20 | Hoechst Ag, 6230 Frankfurt | Pflanzenschuetzende mittel auf basis von 1,2,4-triazolderivaten sowie neue derivate des 1,2,4-triazols |
GB9808663D0 (en) | 1998-04-23 | 1998-06-24 | Merck Sharp & Dohme | Therapeutic agents |
KR100504647B1 (ko) | 1998-12-23 | 2005-07-29 | 화이자 인코포레이티드 | 오피에이트 수용체 리간드로서의 3-아자비시클로[3.1.0.]헥산 유도체 |
US6660753B2 (en) | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
IT1314191B1 (it) | 1999-10-18 | 2002-12-06 | Recordati Chem Pharm | Derivati isossazolcarbossamidici |
EP1228069B1 (en) | 1999-11-12 | 2003-04-02 | Neurogen Corporation | Bicyclic and tricyclic heteroaromatic compounds |
TWI287003B (en) | 2000-07-24 | 2007-09-21 | Hoffmann La Roche | 4-phenyl-pyridine derivatives |
PA8535601A1 (es) | 2000-12-21 | 2002-11-28 | Pfizer | Derivados benzimidazol y piridilimidazol como ligandos para gabaa |
GB0108475D0 (en) | 2001-04-04 | 2001-05-23 | Merck Sharp & Dohme | New compounds |
JP2004536104A (ja) | 2001-07-05 | 2004-12-02 | シナプティック・ファーマスーティカル・コーポレーション | Mch選択的アンタゴニストとしての置換されたアニリン−ピペリジン誘導体 |
DE60225174T2 (de) | 2001-11-20 | 2009-02-12 | Eli Lilly And Co., Indianapolis | Beta-3 adrenergische agonisten |
GB0128160D0 (en) | 2001-11-23 | 2002-01-16 | Merck Sharp & Dohme | Novel compounds |
GB0318447D0 (en) | 2003-08-05 | 2003-09-10 | Merck Sharp & Dohme | Therapeutic agents |
CN1960984B (zh) | 2004-06-01 | 2010-05-12 | 弗·哈夫曼-拉罗切有限公司 | 作为mglu5受体拮抗剂的吡啶-4-基-乙炔基-咪唑和吡唑 |
US20080153869A1 (en) | 2004-06-14 | 2008-06-26 | Bressi Jerome C | Kinase Inhibitors |
WO2006044617A1 (en) | 2004-10-15 | 2006-04-27 | The Scripps Research Institute | Oxadiazole ketone inhibitors of fatty acid amide hydrolase |
EP1814880B1 (en) * | 2004-11-11 | 2009-01-28 | Ferrer Internacional, S.A. | Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto |
US20070060589A1 (en) | 2004-12-21 | 2007-03-15 | Purandare Ashok V | Inhibitors of protein arginine methyl transferases |
-
2007
- 2007-05-21 AU AU2007267183A patent/AU2007267183B2/en not_active Ceased
- 2007-05-21 WO PCT/EP2007/054852 patent/WO2007137954A1/en active Application Filing
- 2007-05-21 CA CA002651857A patent/CA2651857A1/en not_active Abandoned
- 2007-05-21 MX MX2008014796A patent/MX2008014796A/es active IP Right Grant
- 2007-05-21 ES ES07729296T patent/ES2328185T3/es active Active
- 2007-05-21 AT AT07729296T patent/ATE438632T1/de active
- 2007-05-21 BR BRPI0711850-3A patent/BRPI0711850A2/pt not_active IP Right Cessation
- 2007-05-21 CN CN200780019401XA patent/CN101454297B/zh not_active Expired - Fee Related
- 2007-05-21 EP EP07729296A patent/EP2029559B1/en not_active Not-in-force
- 2007-05-21 DE DE602007001893T patent/DE602007001893D1/de active Active
- 2007-05-21 JP JP2009512541A patent/JP5087616B2/ja not_active Expired - Fee Related
- 2007-05-21 KR KR1020087029177A patent/KR101119365B1/ko not_active IP Right Cessation
- 2007-05-24 US US11/805,640 patent/US7544704B2/en not_active Expired - Fee Related
-
2008
- 2008-10-27 IL IL194947A patent/IL194947A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2009538858A (ja) | 2009-11-12 |
ATE438632T1 (de) | 2009-08-15 |
CA2651857A1 (en) | 2007-12-06 |
KR101119365B1 (ko) | 2012-03-07 |
EP2029559B1 (en) | 2009-08-05 |
DE602007001893D1 (en) | 2009-09-17 |
AU2007267183B2 (en) | 2011-10-20 |
US20070287739A1 (en) | 2007-12-13 |
JP5087616B2 (ja) | 2012-12-05 |
CN101454297A (zh) | 2009-06-10 |
EP2029559A1 (en) | 2009-03-04 |
CN101454297B (zh) | 2012-10-31 |
BRPI0711850A2 (pt) | 2011-12-13 |
KR20090006866A (ko) | 2009-01-15 |
MX2008014796A (es) | 2008-12-02 |
IL194947A0 (en) | 2009-08-03 |
WO2007137954A1 (en) | 2007-12-06 |
US7544704B2 (en) | 2009-06-09 |
AU2007267183A1 (en) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2328185T3 (es) | Derivados de aril-4-etinil-isoxazol. | |
CN109476664B (zh) | 作为自分泌运动因子抑制剂的新型化合物和包含其的药物组合物 | |
JP6708661B2 (ja) | Usp30阻害剤としての1−シアノ−ピロリジン化合物 | |
TWI748539B (zh) | Cot調節劑及其使用方法 | |
CN108602776B (zh) | 用作irak抑制剂的杂芳基化合物及其用途 | |
CA2950475C (en) | Indolin-2-one or pyrrolo-pyridin-2-one derivatives | |
JP6453845B2 (ja) | Brd4阻害薬としてのジヒドロキナゾリノン類似体 | |
AU2008295476B2 (en) | 2, 3-Substituted Indole Derivatives for treating viral infections | |
JP5055377B2 (ja) | [5,6−環]環形成インドール誘導体およびその使用方法 | |
EP1968972B1 (en) | Aryl-isoxazolo-4-yl-oxadiazole derivatives | |
JP5416708B2 (ja) | 3−アミノスルホニル置換インドール誘導体およびそれらの使用方法 | |
JP4404896B2 (ja) | イミダゾール−4−イル−エチニル−ピリジン誘導体 | |
KR101228194B1 (ko) | 아이속사졸-이미다졸 유도체 | |
BR112015007731B1 (pt) | Composto, composição farmacêutica que o compreende e uso do mesmo | |
TW201444849A (zh) | 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途 | |
KR20070085371A (ko) | 페녹시 벤즈아미드 화합물의 제조 방법 | |
WO2012117996A1 (ja) | Gpr119作動薬 | |
JP2021070688A (ja) | 難聴の予防および/または治療用医薬組成物 | |
TW201217375A (en) | Diaza-spiro[5.5]undecanes | |
JP2006525993A (ja) | Crf1受容体拮抗剤である化合物 | |
TW201609718A (zh) | 唑啶以及噁嗪烷衍生物 | |
BR112016028315B1 (pt) | Compostos de pirazol, composição farmacêutica, e, uso de um composto como bloqueador do canal de cálcio do tipo t |